DE69629184D1 - Verwendung von vitamin d2 oder vitamin d4-derivaten zur herstellung eines medikamentes zur behandlung des sekundären hyperparathyroidismus - Google Patents
Verwendung von vitamin d2 oder vitamin d4-derivaten zur herstellung eines medikamentes zur behandlung des sekundären hyperparathyroidismusInfo
- Publication number
- DE69629184D1 DE69629184D1 DE69629184T DE69629184T DE69629184D1 DE 69629184 D1 DE69629184 D1 DE 69629184D1 DE 69629184 T DE69629184 T DE 69629184T DE 69629184 T DE69629184 T DE 69629184T DE 69629184 D1 DE69629184 D1 DE 69629184D1
- Authority
- DE
- Germany
- Prior art keywords
- vitamin
- medicine
- derivatives
- producing
- secondary hyperparathyroidism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000005770 Secondary Hyperparathyroidism Diseases 0.000 title 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 title 1
- 150000003706 vitamin D4 derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/16—Fluorine compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US415488 | 1995-04-03 | ||
US08/415,488 US5602116A (en) | 1988-08-02 | 1995-04-03 | Method for treating and preventing secondary hyperparathyroidism |
PCT/US1996/004553 WO1996031215A1 (en) | 1995-04-03 | 1996-04-03 | Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69629184D1 true DE69629184D1 (de) | 2003-08-28 |
DE69629184T2 DE69629184T2 (de) | 2004-05-06 |
Family
ID=23645881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69629184T Expired - Lifetime DE69629184T2 (de) | 1995-04-03 | 1996-04-03 | Verwendung von vitamin d2 oder vitamin d4-derivaten zur herstellung eines medikamentes zur behandlung des sekundären hyperparathyroidismus |
Country Status (18)
Country | Link |
---|---|
US (3) | US5602116A (de) |
EP (1) | EP0820290B1 (de) |
JP (1) | JP3529790B2 (de) |
KR (1) | KR100432265B1 (de) |
CN (1) | CN1214795C (de) |
AU (1) | AU719773B2 (de) |
BR (1) | BR9604940A (de) |
CA (1) | CA2217260C (de) |
DE (1) | DE69629184T2 (de) |
ES (1) | ES2206570T3 (de) |
FI (1) | FI973868A (de) |
HK (1) | HK1008180A1 (de) |
HU (1) | HUP9801777A3 (de) |
MX (1) | MX9707535A (de) |
NO (1) | NO974480L (de) |
NZ (1) | NZ316662A (de) |
PL (1) | PL322613A1 (de) |
WO (1) | WO1996031215A1 (de) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5602116A (en) * | 1988-08-02 | 1997-02-11 | Bone Care International, Inc. | Method for treating and preventing secondary hyperparathyroidism |
US20040009958A1 (en) * | 1991-01-08 | 2004-01-15 | Bone Care International, Inc. | Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2 |
US5763429A (en) | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
US20040043971A1 (en) * | 1995-04-03 | 2004-03-04 | Bone Care International, Inc. | Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
US20020183288A1 (en) * | 1995-04-03 | 2002-12-05 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
US20020128240A1 (en) * | 1996-12-30 | 2002-09-12 | Bone Care International, Inc. | Treatment of hyperproliferative diseases using active vitamin D analogues |
US6503893B2 (en) * | 1996-12-30 | 2003-01-07 | Bone Care International, Inc. | Method of treating hyperproliferative diseases using active vitamin D analogues |
US6566353B2 (en) | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
US6573256B2 (en) | 1996-12-30 | 2003-06-03 | Bone Care International, Inc. | Method of inhibiting angiogenesis using active vitamin D analogues |
US20030129194A1 (en) * | 1997-02-13 | 2003-07-10 | Bone Care International, Inc. | Targeted therapeutic delivery of vitamin D compounds |
HUP0002454A2 (hu) * | 1997-02-13 | 2000-12-28 | Bone Care International, Inc. | D-Vitamin-molekularésszel rendelkező konjugátumok és ilyen konjugátumokat tartalmazó gyógyászati készítmények |
US5962030A (en) | 1997-03-07 | 1999-10-05 | Akesis Pharmaceuticals, Inc. | Dietary supplement and method of treatment for diabetic control |
US6087350A (en) * | 1997-08-29 | 2000-07-11 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Use of pretreatment chemicals to enhance efficacy of cytotoxic agents |
AU762481C (en) * | 1998-03-27 | 2004-08-19 | Oregon Health Sciences University | Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders |
US6376549B1 (en) * | 1998-09-17 | 2002-04-23 | Akesis Pharmaceuticals, Inc. | Metforimin-containing compositions for the treatment of diabetes |
US6852760B1 (en) | 1998-09-17 | 2005-02-08 | Akesis Pharmaceuticals, Inc. | Compositions and methods for treatment for glucose metabolism disorders |
WO2001064251A2 (en) * | 2000-03-02 | 2001-09-07 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Combination chemotherapy |
WO2002006218A2 (en) * | 2000-07-18 | 2002-01-24 | Bone Care International, Inc. | STABILIZED 1α-HYDROXY VITAMIN D |
AU1348302A (en) * | 2000-10-13 | 2002-04-22 | Abbott Lab | A method of determining the initial dose of vitamin d compounds |
US7129230B2 (en) | 2001-03-12 | 2006-10-31 | Nestec S.A. | Method and product for treating cancer in pets |
KR100438254B1 (ko) * | 2001-03-29 | 2004-07-02 | 아이큐어 주식회사 | 비타민 d 유사체를 포함하는 매트릭스형 경피흡수제제 |
ES2192136B1 (es) * | 2002-01-04 | 2005-03-16 | Italfarmaco, S.A. | Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis. |
US7566696B2 (en) | 2002-09-05 | 2009-07-28 | Wisconsin Alumni Research Foundation | Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis |
US20040058895A1 (en) * | 2002-09-18 | 2004-03-25 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
WO2004028515A1 (en) * | 2002-09-26 | 2004-04-08 | Young-Kweon Choi | Matrix type patch for transdermal administration of vitamin d analog and the use thereof |
TWI335218B (en) | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
US8093423B2 (en) | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
WO2004098617A2 (en) * | 2003-05-07 | 2004-11-18 | Osteologix A/S | Controlled release composition containing a strontium salt |
SI1622630T1 (sl) * | 2003-05-07 | 2012-12-31 | Osteologix A/S | Stroncijeva kombinacije za profilakso/zdravljenje patologij hrustanca in/ali kosti |
JP4354984B2 (ja) * | 2003-05-07 | 2009-10-28 | オステオロジックス エイ/エス | 水溶性ストロンチウム塩を用いる軟骨/骨症状の治療 |
WO2005102355A1 (en) * | 2004-04-23 | 2005-11-03 | Genzyme Corporation | METHODS OF TREATING VARIOUS VITAMIN D METABOLISM CONDITIONS WITH 1α-HYDROXYVITAMIN D2 |
US20060003950A1 (en) * | 2004-06-30 | 2006-01-05 | Bone Care International, Inc. | Method of treating prostatic diseases using a combination of vitamin D analogues and other agents |
US7094775B2 (en) * | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
EP1848455A1 (de) * | 2005-02-14 | 2007-10-31 | Wisconsin Alumni Research Foundation | Verwendung von calcitonin und calcitonin-ähnlichen peptiden zur behandlung und vorbeugung von multipler sklerose |
CA2924200C (en) * | 2005-10-12 | 2017-09-05 | Proventiv Therapeutics, Llc | Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
ES2580127T3 (es) * | 2006-01-30 | 2016-08-19 | Panion & Bf Biotech Inc. | Procedimiento de tratamiento de la nefropatía crónica |
HUE029572T2 (en) * | 2006-02-03 | 2017-03-28 | Opko Renal Llc | Treatment of Vitamin D Insufficiency and Deficiency with 25-Hydroxy-D2 and 25-Hydroxy-D3 |
US8329677B2 (en) | 2006-06-21 | 2012-12-11 | Cytochroma, Inc. | Method of treating and preventing secondary hyperparathyroidism |
AU2007325387B2 (en) * | 2006-11-16 | 2014-04-03 | Kai Pharmaceuticals, Inc. | Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders |
WO2008134523A1 (en) | 2007-04-25 | 2008-11-06 | Proventiv Therapeutics, Llc | Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
WO2008134518A2 (en) * | 2007-04-25 | 2008-11-06 | Cytochroma Inc. | Methods and compounds for vitamin d therapy |
EP3542792B1 (de) | 2007-04-25 | 2023-06-28 | EirGen Pharma Ltd. | Kontrollierte freisetzung 25-hydroxyvitamin d |
KR101495578B1 (ko) * | 2007-04-25 | 2015-02-25 | 사이토크로마 인코포레이티드 | 비타민 d 부족 및 결핍의 치료 방법 |
KR101852042B1 (ko) | 2008-04-02 | 2018-04-25 | 사이토크로마 인코포레이티드 | 비타민 d 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트 |
RU2563819C2 (ru) | 2009-07-21 | 2015-09-20 | Керикс Байофармасьютикалз, Инк. | Лекарственные формы цитрата железа (iii) |
ES2607954T3 (es) | 2009-07-29 | 2017-04-04 | Kai Pharmaceuticals, Inc. | Agentes terapéuticos para reducir los niveles de hormona paratiroidea |
US7886904B1 (en) * | 2009-07-30 | 2011-02-15 | Owens Corning Intellectual Capital, Llc | Loosefill package for blowing wool machine |
LT2552484T (lt) | 2010-03-29 | 2020-04-27 | Opko Ireland Global Holdings, Ltd. | Būdai ir kompozicijos, skirti paratiroidų lygiams sumažinti |
CA2698160C (en) * | 2010-03-30 | 2017-07-25 | Alphora Research Inc. | Stabilized doxercalciferol and process for manufacturing the same |
BR112012026361A2 (pt) * | 2010-04-16 | 2019-09-24 | Baxter Healthcare Sa | previsão de terapia e otimização de terapia sanguínea para insuficiência renal, especialmente hemodiálise domiciliar |
BR112013031539A2 (pt) | 2011-06-08 | 2019-07-30 | Kai Pharmaceuticals Inc | agentes terapêuticos para regular fósforo sérico |
EP2776129B2 (de) | 2011-11-10 | 2020-06-17 | Kai Pharmaceuticals, Inc. | Zusammensetzungen zur verwendung bei der behandlung von chronische renale osteodystrophie gekennzeichnet durch verkalkung der weichteile |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
MX2016010892A (es) * | 2014-02-26 | 2016-11-17 | Nippon Zoki Pharmaceutical Co | Agente para suprimir el progreso de o para mejorar la enfermedad renal cronica. |
CN114681468A (zh) | 2014-08-07 | 2022-07-01 | 欧普科爱尔兰环球控股有限公司 | 利用25-羟基维生素d的辅助疗法 |
JP6520510B2 (ja) * | 2015-07-15 | 2019-05-29 | 富士ゼロックス株式会社 | 情報処理装置及び情報処理プログラム |
TW202214257A (zh) | 2016-03-28 | 2022-04-16 | 愛爾蘭商歐科愛爾蘭全球控股股份有限公司 | 維生素d治療之方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3907843A (en) * | 1974-06-14 | 1975-09-23 | Wisconsin Alumni Res Found | 1{60 -Hydroxyergocalciferol and processes for preparing same |
US4202829A (en) * | 1978-01-05 | 1980-05-13 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
US4195027A (en) * | 1978-01-16 | 1980-03-25 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
US4260549A (en) * | 1979-05-21 | 1981-04-07 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
US4225596A (en) * | 1978-10-13 | 1980-09-30 | Wisconsin Alumni Research Foundation | Method for treating calcium imbalance and improving calcium absorption in mammals |
US4234495A (en) * | 1979-09-10 | 1980-11-18 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxyvitamin D compounds from 1α-hydroxy-3,5-cyclovitamin D compounds |
US4554106A (en) * | 1984-11-01 | 1985-11-19 | Wisconsin Alumni Research Foundation | Method for preparing 1α-hydroxyvitamin D compounds |
US4555364A (en) * | 1984-11-01 | 1985-11-26 | Wisconsin Alumni Research Foundation | Method for preparing 1-hydroxyvitamin D compounds |
IL78342A (en) * | 1985-04-04 | 1991-06-10 | Gen Hospital Corp | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof |
US4833125A (en) * | 1986-12-05 | 1989-05-23 | The General Hospital Corporation | Method of increasing bone mass |
US5602116A (en) * | 1988-08-02 | 1997-02-11 | Bone Care International, Inc. | Method for treating and preventing secondary hyperparathyroidism |
US5104864A (en) * | 1988-08-02 | 1992-04-14 | Bone Care International, Inc. | Method for treating and preventing loss of bone mass |
GB2229921B (en) * | 1989-04-05 | 1992-12-16 | Chugai Pharmaceutical Co Ltd | Treatment for hyperparathyroidism with use of vitamin d derivatives |
ES2169023T3 (es) * | 1990-09-21 | 2002-07-01 | Bone Care Int Inc | Nueva 1alfa-hidroxi vitaminada d4 y nuevos intermedios y analogos. |
ATE240736T1 (de) * | 1991-01-08 | 2003-06-15 | Bone Care Int Inc | Verfahren zur herstellung von 1-alpha-24- dihydroxy-vitamin d2 |
DK0503630T3 (da) * | 1991-03-13 | 1996-01-29 | Kuraray Co | Cyclohexantriolderivater |
CA2129120A1 (en) * | 1992-01-29 | 1993-08-05 | Joyce C. Knutson | 1.alpha.-hydroxy-24-epi-vitamin d4 |
EP0562497A1 (de) * | 1992-03-27 | 1993-09-29 | Nisshin Flour Milling Co., Ltd. | 1-Alpha-Hydroxy-Vitamine D7 und D4', Verfahren zur ihren Herstellung und pharmazeutische Präparate davon |
EP0614456B1 (de) * | 1992-08-28 | 1999-06-09 | Bone Care International, Inc. | 1alpha,24(s)-dihydroxy vitamin d2, seine synthese und verwendung |
US5350745A (en) * | 1993-01-29 | 1994-09-27 | Lunar Corporation | Treatment of myocardial failure |
-
1995
- 1995-04-03 US US08/415,488 patent/US5602116A/en not_active Expired - Lifetime
-
1996
- 1996-04-03 JP JP53044696A patent/JP3529790B2/ja not_active Expired - Lifetime
- 1996-04-03 PL PL96322613A patent/PL322613A1/xx unknown
- 1996-04-03 BR BR9604940A patent/BR9604940A/pt not_active Application Discontinuation
- 1996-04-03 KR KR1019970706941A patent/KR100432265B1/ko not_active IP Right Cessation
- 1996-04-03 ES ES96910720T patent/ES2206570T3/es not_active Expired - Lifetime
- 1996-04-03 WO PCT/US1996/004553 patent/WO1996031215A1/en active IP Right Grant
- 1996-04-03 DE DE69629184T patent/DE69629184T2/de not_active Expired - Lifetime
- 1996-04-03 NZ NZ316662A patent/NZ316662A/en unknown
- 1996-04-03 EP EP96910720A patent/EP0820290B1/de not_active Expired - Lifetime
- 1996-04-03 CA CA002217260A patent/CA2217260C/en not_active Expired - Lifetime
- 1996-04-03 AU AU53840/96A patent/AU719773B2/en not_active Expired
- 1996-04-03 CN CNB961940980A patent/CN1214795C/zh not_active Expired - Lifetime
- 1996-04-03 HU HU9801777A patent/HUP9801777A3/hu unknown
-
1997
- 1997-02-11 US US08/798,958 patent/US5707980A/en not_active Expired - Lifetime
- 1997-08-08 US US08/907,658 patent/US5861386A/en not_active Expired - Fee Related
- 1997-09-29 NO NO974480A patent/NO974480L/no not_active Application Discontinuation
- 1997-10-01 MX MX9707535A patent/MX9707535A/es unknown
- 1997-10-02 FI FI973868A patent/FI973868A/fi unknown
-
1998
- 1998-07-14 HK HK98109130A patent/HK1008180A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HUP9801777A3 (en) | 1999-05-28 |
WO1996031215A1 (en) | 1996-10-10 |
FI973868A0 (fi) | 1997-10-02 |
PL322613A1 (en) | 1998-02-02 |
HUP9801777A2 (hu) | 1998-11-30 |
ES2206570T3 (es) | 2004-05-16 |
KR19980703537A (ko) | 1998-11-05 |
AU719773B2 (en) | 2000-05-18 |
CA2217260C (en) | 2000-08-01 |
JP3529790B2 (ja) | 2004-05-24 |
NZ316662A (en) | 2001-04-27 |
US5861386A (en) | 1999-01-19 |
KR100432265B1 (ko) | 2004-09-10 |
NO974480D0 (no) | 1997-09-29 |
US5707980A (en) | 1998-01-13 |
EP0820290A1 (de) | 1998-01-28 |
AU5384096A (en) | 1996-10-23 |
US5602116A (en) | 1997-02-11 |
CN1185109A (zh) | 1998-06-17 |
MX9707535A (es) | 1998-07-31 |
EP0820290B1 (de) | 2003-07-23 |
CA2217260A1 (en) | 1996-10-10 |
CN1214795C (zh) | 2005-08-17 |
NO974480L (no) | 1997-11-14 |
FI973868A (fi) | 1997-10-02 |
DE69629184T2 (de) | 2004-05-06 |
HK1008180A1 (en) | 1999-05-07 |
JPH11503164A (ja) | 1999-03-23 |
BR9604940A (pt) | 1998-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69629184D1 (de) | Verwendung von vitamin d2 oder vitamin d4-derivaten zur herstellung eines medikamentes zur behandlung des sekundären hyperparathyroidismus | |
DE3585607D1 (de) | Verwendung von paroxetine zur herstellung eines arzneimittel zur behandlung von obesitaet. | |
DE69626539D1 (de) | topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen | |
DE122005000002I1 (de) | Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz. | |
DE69435330D1 (de) | Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Behandlung von Muskelkrämpfen | |
ATE330593T1 (de) | Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen | |
DE60015392D1 (de) | Verwendung von annexin-modulatoren zur herstellung eines medikaments zur behandlung und/oder vorbeugung von arthritis und arthritischen erkrankungen | |
DE3484055D1 (de) | Verwendung von ubidecarenon zur herstellung eines medikaments zur behandlung von durch radiotherapie hervorgerufenen geschwueren. | |
ATE221763T1 (de) | Die verwendung von glyceryltriacetat zur behandlung von onychomykosen | |
DE69637449D1 (de) | Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen | |
DE69233725D1 (de) | Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren | |
DE69331833D1 (de) | Verwendung von vitamin d-glykosiden zur behandlung oder prävention von osteoporose | |
DE69621447D1 (de) | Verwendung von nitroflavonoide zur behandlung von angstzuständen | |
DE59202663D1 (de) | Verwendung eines UV-Strahlers zur Behandlung von Oberflächen. | |
DE3675115D1 (de) | Verwendung von verbindungen zur herstellung eines medikaments fuer die behandlung von grauem star. | |
ATE135220T1 (de) | Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose | |
DE3768150D1 (de) | Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie. | |
DE69620786D1 (de) | Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie | |
ATA32291A (de) | Verwendung eines bakterien-lysats zur herstellung eines medikaments zur behandlung der atopischen dermatitis | |
DE68905657T2 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
DE69515666D1 (de) | VERWENDUNG VON GnRH-ANTAGONISTEN ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR BEHANDLUNG GONADEN-STEROID ABHÄNGIGER ERKRANKUNGEN | |
DE69610045D1 (de) | Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen | |
DE69909798D1 (de) | Verwendung von calix(n)arenen zur herstellung eines medikamentes zur behandlung von fibrotischen krankheiten | |
ATE263565T1 (de) | Verwendung von 8,9-dehydroestron zur herstellung eines arzneimittels zur behandlung von durch freie radikale verursachte krankheiten | |
DE68906700T2 (de) | Verwendung eines polypeptids zur herstellung einer zusammensetzung zur behandlung von pankreatitis. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |